{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:45:42Z","timestamp":1782467142415,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01227-x","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:46:22Z","timestamp":1782463582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review"],"prefix":"10.1007","volume":"28","author":[{"given":"Elisa","family":"Bazin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-3169","authenticated-orcid":false,"given":"Nihal","family":"Martis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"1227_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","volume":"403","author":"A Kronbichler","year":"2024","unstructured":"Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH. Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024;403:683\u201398. https:\/\/doi.org\/10.1016\/S0140-6736(23)01736-1.","journal-title":"Lancet"},{"key":"1227_CR2","doi-asserted-by":"publisher","first-page":"m421","DOI":"10.1136\/bmj.m421","volume":"368","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Miloslavsky EM. Management of ANCA associated vasculitis. BMJ. Br Med J Publishing Group. 2020;368:m421. https:\/\/doi.org\/10.1136\/bmj.m421.","journal-title":"Br Med J Publishing Group"},{"key":"1227_CR3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/rheumatology\/keac623","volume":"62","author":"B Chevet","year":"2023","unstructured":"Chevet B, Cornec D, Casal Moura M, Cornec-Le Gall E, Fervenza FC, Warrington KJ, et al. Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice. Rheumatology. 2023;62:1787\u2013803. https:\/\/doi.org\/10.1093\/rheumatology\/keac623.","journal-title":"Rheumatology"},{"key":"1227_CR4","doi-asserted-by":"publisher","unstructured":"Wallace ZS, Fu X, Harkness T, Stone JH, Zhang Y, Choi H. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology. Oxford, England; 2020;59:2308\u201315. https:\/\/doi.org\/10.1093\/rheumatology\/kez589","DOI":"10.1093\/rheumatology\/kez589"},{"key":"1227_CR5","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1093\/ndt\/gfaf070","volume":"40","author":"A Sarmad","year":"2025","unstructured":"Sarmad A, Gholizadeh Ghozloujeh Z, Hanna PE, Kronbichler A, Geetha D, Heidari-Bateni G, et al. Cardiovascular involvement in ANCA-associated vasculitis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2025;40:2256\u201367. https:\/\/doi.org\/10.1093\/ndt\/gfaf070.","journal-title":"Eur Ren Assoc"},{"key":"1227_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/ndt\/gfac320","volume":"38","author":"B S\u00e1nchez \u00c1lamo","year":"2023","unstructured":"S\u00e1nchez \u00c1lamo B, Moi L, Bajema I, Faurschou M, Flossmann O, Hauser T, et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2023;38:1655\u201365. https:\/\/doi.org\/10.1093\/ndt\/gfac320.","journal-title":"Eur Ren Assoc"},{"key":"1227_CR7","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.jaut.2019.102397","volume":"108","author":"L Quartuccio","year":"2020","unstructured":"Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, et al. Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors. J Autoimmun. 2020;108:102397. https:\/\/doi.org\/10.1016\/j.jaut.2019.102397.","journal-title":"J Autoimmun"},{"key":"1227_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00296-025-05812-8","volume":"45","author":"M Schaier","year":"2025","unstructured":"Schaier M, K\u00e4lble F, Benning L, Reichel P, Mahler C, Nusshag C, et al. ANCA-associated vasculitis and the impact of diffuse alveolar hemorrhage in elderly patients: a retrospective cohort study. Rheumatol Int. 2025;45:68. https:\/\/doi.org\/10.1007\/s00296-025-05812-8.","journal-title":"Rheumatol Int"},{"key":"1227_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-023-07266-7","volume":"50","author":"G Dumas","year":"2024","unstructured":"Dumas G, Arabi YM, Bartz R, Ranzani O, Scheibe F, Darmon M, et al. Diagnosis and management of autoimmune diseases in the ICU. Intensive Care Med. 2024;50:17\u201335. https:\/\/doi.org\/10.1007\/s00134-023-07266-7.","journal-title":"Intensive Care Med"},{"key":"1227_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11926-021-01010-0","volume":"23","author":"S Monti","year":"2021","unstructured":"Monti S, Brandolino F, Milanesi A, Xoxi B, Delvino P, Montecucco C. Novel Therapies for ANCA-associated Vasculitis. Curr Rheumatol Rep. 2021;23:38. https:\/\/doi.org\/10.1007\/s11926-021-01010-0.","journal-title":"Curr Rheumatol Rep"},{"key":"1227_CR11","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.3390\/ijms26125902","volume":"26","author":"M Apetrii","year":"2025","unstructured":"Apetrii M, Costache AD, Costache Enache II, Voroneanu L, Covic AS, Kanbay M, et al. Complement System Inhibitors in Nephrology: An Update-Narrative Review. Int J Mol Sci. 2025;26:5902. https:\/\/doi.org\/10.3390\/ijms26125902.","journal-title":"Int J Mol Sci"},{"key":"1227_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ndt\/gfaa312","volume":"36","author":"U Specks","year":"2021","unstructured":"Specks U, Fussner LA, Cartin-Ceba R, Casal Moura M, Zand L, Fervenza FC. Plasma exchange for the management of ANCA-associated vasculitis: the con position. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2021;36:231\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfaa312.","journal-title":"Eur Ren Assoc"},{"key":"1227_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/ndt\/gfaa311","volume":"36","author":"A Kronbichler","year":"2021","unstructured":"Kronbichler A, Shin JI, Wang C-S, Szpirt WM, Segelmark M, Tesar V. Plasma exchange in ANCA-associated vasculitis: the pro position. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2021;36:227\u201331. https:\/\/doi.org\/10.1093\/ndt\/gfaa311.","journal-title":"Eur Ren Assoc"},{"key":"1227_CR14","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.3390\/jcm10215154","volume":"10","author":"S Tsiakas","year":"2021","unstructured":"Tsiakas S, Marinaki S, Lionaki S, Boletis J. Plasma Exchange in ANCA-Associated Vasculitis: A Narrative Review. J Clin Med. 2021;10:5154. https:\/\/doi.org\/10.3390\/jcm10215154.","journal-title":"J Clin Med"},{"key":"1227_CR15","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DRW Jayne","year":"2007","unstructured":"Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol JASN. 2007;18:2180\u20138. https:\/\/doi.org\/10.1681\/ASN.2007010090.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1227_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. N Engl J Med. 2010;363:221\u201332. https:\/\/doi.org\/10.1056\/NEJMoa0909905.","journal-title":"N Engl J Med"},{"key":"1227_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Cohen Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis. N Engl J Med. 2010;363:211\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0909169.","journal-title":"N Engl J Med"},{"key":"1227_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh C-A, Szpirt WM, Pu\u00e9chal X, Fujimoto S, et al. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N Engl J Med. 2020;382:622\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1803537.","journal-title":"N Engl J Med"},{"key":"1227_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med Mass Med Soc. 2021;384:599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa2023386.","journal-title":"N Engl J Med Mass Med Soc"},{"key":"1227_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13054-016-1189-5","volume-title":"Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study","author":"A Kimmoun","year":"2016","unstructured":"Kimmoun A, Baux E, Das V, Terzi N, Talec P, Asfar P, et al. Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Volume 20. London, England: Crit Care; 2016. p. 27. https:\/\/doi.org\/10.1186\/s13054-016-1189-5."},{"key":"1227_CR21","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.3390\/jcm13195688","volume":"13","author":"K Rukavina","year":"2024","unstructured":"Rukavina K, Zlopasa O, Vukovic Brinar I, Dzubur F, Anic B, Vujaklija Brajkovic A. Critically Ill Patients with Newly Diagnosed Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Case Series and Literature Review. J Clin Med. 2024;13:5688. https:\/\/doi.org\/10.3390\/jcm13195688.","journal-title":"J Clin Med"},{"key":"1227_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13613-017-0262-9","volume":"7","author":"J Demiselle","year":"2017","unstructured":"Demiselle J, Auchabie J, Beloncle F, Gatault P, Grang\u00e9 S, Du Cheyron D, et al. Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study. Ann Intensive Care. 2017;7:39. https:\/\/doi.org\/10.1186\/s13613-017-0262-9.","journal-title":"Ann Intensive Care"},{"key":"1227_CR23","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/jcm14051724","volume":"14","author":"Y Horai","year":"2025","unstructured":"Horai Y, Kurushima S, Kawakami A. Current Diagnosis and Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Review Including a Comparison of Characteristics in Europe and Japan. J Clin Med. 2025;14:1724. https:\/\/doi.org\/10.3390\/jcm14051724.","journal-title":"J Clin Med"},{"key":"1227_CR24","doi-asserted-by":"publisher","first-page":"210123","DOI":"10.1183\/16000617.0123-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review. Eur Respir Rev Off J Eur Respir Soc. 2021;30:210123. https:\/\/doi.org\/10.1183\/16000617.0123-2021.","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"1227_CR25","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1136\/annrheumdis-2023-eular.3279","volume":"82","author":"C Cobilinschi","year":"2023","unstructured":"Cobilinschi C, Juganaru E, Caraiola S, Ionescu R, Jurcut C, Saulescu I, et al. Ab0780 Time Management and Risk Factors in Life-Threatening Anca-Vasculitis. Ann Rheum Dis BMJ Publishing Group Ltd. 2023;82:1600\u20131600. https:\/\/doi.org\/10.1136\/annrheumdis-2023-eular.3279.","journal-title":"Ann Rheum Dis BMJ Publishing Group Ltd"},{"key":"1227_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13054-020-02936-0","volume":"24","author":"A Mirouse","year":"2020","unstructured":"Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, G\u00e9ri G, et al. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Crit Care Lond Engl. 2020;24:231. https:\/\/doi.org\/10.1186\/s13054-020-02936-0.","journal-title":"Crit Care Lond Engl"},{"key":"1227_CR27","doi-asserted-by":"publisher","unstructured":"Boyle N, O\u2019Callaghan M, Ataya A, Gupta N, Keane MP, Murphy DJ, et al. Pulmonary renal syndrome: a clinical review. Breathe [Internet] Eur Respiratory Soc. 2023;18. https:\/\/doi.org\/10.1183\/20734735.0208-2022. [cited 2026 Mar 15];.","DOI":"10.1183\/20734735.0208-2022"},{"key":"1227_CR28","doi-asserted-by":"publisher","first-page":"103863","DOI":"10.1016\/j.autrev.2025.103863","volume":"24","author":"F-J Cordero-P\u00e9rez","year":"2025","unstructured":"Cordero-P\u00e9rez F-J, Mart\u00ednez-Rodr\u00edguez P, Arribas-P\u00e9rez L, Puertas-Miranda D, Pires-Baltazar C-R, Salcedo-Mart\u00edn L, et al. Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain\u2019s National Health Data (2016\u20132022). Autoimmun Rev. 2025;24:103863. https:\/\/doi.org\/10.1016\/j.autrev.2025.103863.","journal-title":"Autoimmun Rev"},{"key":"1227_CR29","doi-asserted-by":"publisher","first-page":"iii79","DOI":"10.1093\/rheumatology\/kez617","volume":"59","author":"A Kronbichler","year":"2020","unstructured":"Kronbichler A, Leierer J, Gauckler P, Shin JI. Comorbidities in ANCA-associated vasculitis. Rheumatol Oxf Engl. 2020;59:iii79\u201383. https:\/\/doi.org\/10.1093\/rheumatology\/kez617.","journal-title":"Rheumatol Oxf Engl"},{"key":"1227_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis BMJ Publishing Group Ltd. 2024;83:30\u201347. https:\/\/doi.org\/10.1136\/ard-2022-223764.","journal-title":"Ann Rheum Dis BMJ Publishing Group Ltd"},{"key":"1227_CR31","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.3390\/jcm10173773","volume":"10","author":"E Treppo","year":"2021","unstructured":"Treppo E, Binutti M, Agarinis R, De Vita S, Quartuccio L. Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives. J Clin Med. 2021;10:3773. https:\/\/doi.org\/10.3390\/jcm10173773.","journal-title":"J Clin Med"},{"key":"1227_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/ard-2023-224623","volume":"83","author":"F Delestre","year":"2024","unstructured":"Delestre F, Charles P, Karras A, Pagnoux C, N\u00e9el A, Cohen P, et al. Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials. Ann Rheum Dis BMJ Publishing Group Ltd. 2024;83:233\u201341. https:\/\/doi.org\/10.1136\/ard-2023-224623.","journal-title":"Ann Rheum Dis BMJ Publishing Group Ltd"},{"key":"1227_CR33","doi-asserted-by":"publisher","unstructured":"Wallace ZS, Fu X, Cook C, Ahola C, Williams Z, Doliner B et al. Comparative Effectiveness of Rituximab- Versus Cyclophosphamide-Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the Risk of Kidney Failure and Mortality. Arthritis Rheumatol. Hoboken, N.J.; 2023;75:1599\u2013607. https:\/\/doi.org\/10.1002\/art.42515","DOI":"10.1002\/art.42515"},{"key":"1227_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/ard-2023-224472","volume":"83","author":"Y Ishikawa","year":"2024","unstructured":"Ishikawa Y, Tokutsu K, Nakayamada S, Kuchiba A, Fushimi K, Matsuda S, et al. Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database. Ann Rheum Dis. 2024;83:103\u201311. https:\/\/doi.org\/10.1136\/ard-2023-224472.","journal-title":"Ann Rheum Dis"},{"key":"1227_CR35","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/1529-0131(199810)41","volume":"41","author":"M Haubitz","year":"1998","unstructured":"Haubitz M, Schellong S, G\u00f6bel U, Schurek HJ, Schaumann D, Koch KM, et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study. Arthritis Rheum. 1998;41:1835\u201344. https:\/\/doi.org\/10.1002\/1529-0131(199810)41. :10%3C1835::AID-ART16%3E3.0.CO;2-Q.","journal-title":"Arthritis Rheum"},{"key":"1227_CR36","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10067-017-3944-7","volume":"37","author":"J La-Crette","year":"2018","unstructured":"La-Crette J, Royle J, Lanyon PC, Ferraro A, Butler A, Pearce FA. Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis. Clin Rheumatol. 2018;37:1085\u201390. https:\/\/doi.org\/10.1007\/s10067-017-3944-7.","journal-title":"Clin Rheumatol"},{"key":"1227_CR37","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/ndt\/gfae020","volume":"39","author":"A Chalkia","year":"2024","unstructured":"Chalkia A, Flossmann O, Jones R, Nair JR, Simpson T, Smith R, et al. Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage. Nephrol Dial Transpl. 2024;39:1473\u201382. https:\/\/doi.org\/10.1093\/ndt\/gfae020.","journal-title":"Nephrol Dial Transpl"},{"key":"1227_CR38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/acr2.11726","volume":"6","author":"SD Falde","year":"2024","unstructured":"Falde SD, Lal A, Cartin-Ceba R, Mertz LE, Fervenza FC, Zand L, et al. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ACR Open Rheumatol. 2024;6:707\u201316. https:\/\/doi.org\/10.1002\/acr2.11726.","journal-title":"ACR Open Rheumatol"},{"key":"1227_CR39","unstructured":"Center for Drug Evaluation and Research (FDA Drug Safety Communication). FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Vasculitis. FDA [Internet]. FDA. 2026 [cited 2026 May 3]; https:\/\/www.fda.gov\/drugs\/drug-safety-communications\/fda-identifies-cases-serious-liver-injury-patients-taking-tavneos-avacopan-severe-active-anti. Accessed 3 May 2026."},{"key":"1227_CR40","unstructured":"Center for Drug Evaluation and Research (FDA Drug Safety Communication). CDER proposes to withdraw approval of TAVNEOS. FDA [Internet]. FDA. 2026 [cited 2026 May 3]; https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/cder-proposes-withdraw-approval-tavneos. Accessed 3 May 2026."},{"key":"1227_CR41","doi-asserted-by":"publisher","unstructured":"Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet. London, England; 2006;368:404\u201318. https:\/\/doi.org\/10.1016\/S0140-6736(06)69114-9","DOI":"10.1016\/S0140-6736(06)69114-9"},{"key":"1227_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"M Walsh","year":"2013","unstructured":"Walsh M, Casian A, Flossmann O, Westman K, H\u00f6glund P, Pusey C, et al. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int. 2013;84:397\u2013402. https:\/\/doi.org\/10.1038\/ki.2013.131.","journal-title":"Kidney Int"},{"key":"1227_CR43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ki.1991.272","volume":"40","author":"CD Pusey","year":"1991","unstructured":"Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 1991;40:757\u201363. https:\/\/doi.org\/10.1038\/ki.1991.272.","journal-title":"Kidney Int"},{"key":"1227_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.kint.2024.11.029","volume":"107","author":"B Odler","year":"2025","unstructured":"Odler B, Riedl R, Geetha D, Szpirt WM, Hawley C, Uchida L, et al. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial. Kidney Int. 2025;107:558\u201367. https:\/\/doi.org\/10.1016\/j.kint.2024.11.029.","journal-title":"Kidney Int"},{"key":"1227_CR45","doi-asserted-by":"publisher","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","volume":"376","author":"M Walsh","year":"2022","unstructured":"Walsh M, Collister D, Zeng L, Merkel PA, Pusey CD, Guyatt G, et al. The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis. BMJ Clin Res ed. 2022;376:e064604. https:\/\/doi.org\/10.1136\/bmj-2021-064604.","journal-title":"BMJ Clin Res ed"},{"key":"1227_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1681\/ASN.2021060771","volume":"33","author":"D Nezam","year":"2022","unstructured":"Nezam D, Porcher R, Grolleau F, Morel P, Titeca-Beauport D, Faguer S, et al. Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges. J Am Soc Nephrol JASN. 2022;33:628\u201337. https:\/\/doi.org\/10.1681\/ASN.2021060771.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1227_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apheresis. 2023;38:77\u2013278. https:\/\/doi.org\/10.1002\/jca.22043.","journal-title":"J Clin Apheresis"},{"key":"1227_CR48","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Kidney Int. 2024;105:S71\u2013116. https:\/\/doi.org\/10.1016\/j.kint.2023.10.008.","journal-title":"Kidney Int"},{"key":"1227_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa0910500","volume":"363","author":"V Pedchenko","year":"2010","unstructured":"Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis. N Engl J Med Mass Med Soc. 2010;363:343\u201354. https:\/\/doi.org\/10.1056\/NEJMoa0910500.","journal-title":"N Engl J Med Mass Med Soc"},{"key":"1227_CR50","doi-asserted-by":"publisher","unstructured":"Terrier B, Charles P, Auma\u00eetre O, Belot A, Bonnotte B, Crabol Y et al. ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance. Presse Med. Paris, France : 1983; 2020;49:104031. https:\/\/doi.org\/10.1016\/j.lpm.2020.104031","DOI":"10.1016\/j.lpm.2020.104031"},{"key":"1227_CR51","unstructured":"Vascularites associ\u00e9es aux ANCA [Internet]. Haute Aut. Sant\u00e9. [cited 2026 Mar 29]. https:\/\/www.has-sante.fr\/jcms\/p_3858403\/fr\/vascularites-associees-aux-anca. Accessed 29 Mar 2026."},{"key":"1227_CR52","doi-asserted-by":"publisher","unstructured":"Sanna A-C, Gendreau S, Desnos C, Lombardi R, Malherbe J, Titeca-Beauport D, et al. Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial. Am J Respir Crit Care Med. 2026;aamaf122. https:\/\/doi.org\/10.1093\/ajrccm\/aamaf122.","DOI":"10.1093\/ajrccm\/aamaf122"},{"key":"1227_CR53","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.24634","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res. 2021;73:1088\u2013105. https:\/\/doi.org\/10.1002\/acr.24634.","journal-title":"Arthritis Care Res"},{"key":"1227_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/ndt\/gfx378","volume":"34","author":"SP McAdoo","year":"2019","unstructured":"McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J, et al. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2019;34:63\u201373. https:\/\/doi.org\/10.1093\/ndt\/gfx378.","journal-title":"Eur Ren Assoc"},{"key":"1227_CR55","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1093\/rheumatology\/keaf240","volume":"64","author":"K Biddle","year":"2025","unstructured":"Biddle K, Jade J, Wilson-Morkeh H, Adikari M, Yaghchi CA, Anastasa Z, et al. The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. Rheumatol Oxf Engl. 2025;64:4470\u201394. https:\/\/doi.org\/10.1093\/rheumatology\/keaf240.","journal-title":"Rheumatol Oxf Engl"},{"key":"1227_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","volume":"20","author":"D Chanouzas","year":"2019","unstructured":"Chanouzas D, McGregor JAG, Nightingale P, Salama AD, Szpirt WM, Basu N, et al. Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study. BMC Nephrol. 2019;20:58. https:\/\/doi.org\/10.1186\/s12882-019-1226-0.","journal-title":"BMC Nephrol"},{"key":"1227_CR57","doi-asserted-by":"publisher","first-page":"e19173","DOI":"10.1097\/MD.0000000000019173","volume":"99","author":"D Waki","year":"2020","unstructured":"Waki D, Nishimura K, Tokumasu H, Kadoba K, Mukoyama H, Saito R, et al. Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: A retrospective observational study. Med (Baltim). 2020;99:e19173. https:\/\/doi.org\/10.1097\/MD.0000000000019173.","journal-title":"Med (Baltim)"},{"key":"1227_CR58","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.chest.2017.01.004","volume":"151","author":"Y-N Ni","year":"2017","unstructured":"Ni Y-N, Luo J, Yu H, Liu D, Ni Z, Cheng J, et al. Can High-flow Nasal Cannula Reduce the Rate of Endotracheal Intubation in Adult Patients With Acute Respiratory Failure Compared With Conventional Oxygen Therapy and Noninvasive Positive Pressure Ventilation? A Systematic Review and Meta-analysis. Chest. 2017;151:764\u201375. https:\/\/doi.org\/10.1016\/j.chest.2017.01.004.","journal-title":"Chest"},{"key":"1227_CR59","doi-asserted-by":"publisher","first-page":"104284","DOI":"10.1016\/j.amsu.2022.104284","volume":"80","author":"BA Admass","year":"2022","unstructured":"Admass BA, Endalew NS, Tawye HY, Melesse DY, Workie MM, Filatie TD. Evidence-based airway management protocol for a critical ill patient in medical intensive care unit: Systematic review. Ann Med Surg. 2022;80:104284. https:\/\/doi.org\/10.1016\/j.amsu.2022.104284.","journal-title":"Ann Med Surg"},{"key":"1227_CR60","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"RG Brower","year":"2000","unstructured":"Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301\u20138. https:\/\/doi.org\/10.1056\/NEJM200005043421801.","journal-title":"N Engl J Med"},{"key":"1227_CR61","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1164\/rccm.202308-1426OC","volume":"209","author":"LA Fussner","year":"2024","unstructured":"Fussner LA, Flores-Su\u00e1rez LF, Cartin-Ceba R, Specks U, Cox PG, Jayne DRW, et al. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). Am J Respir Crit Care Med. 2024;209:1141\u201351. https:\/\/doi.org\/10.1164\/rccm.202308-1426OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1227_CR62","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","volume":"368","author":"C Gu\u00e9rin","year":"2013","unstructured":"Gu\u00e9rin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159\u201368. https:\/\/doi.org\/10.1056\/NEJMoa1214103.","journal-title":"N Engl J Med"},{"key":"1227_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/aor.13861","volume":"45","author":"HG Reddy","year":"2021","unstructured":"Reddy HG, Maynes EJ, Saxena A, Austin MA, O\u2019Malley TJ, Gadda MN, et al. Utilization of extracorporeal life support for diffuse alveolar damage and diffuse alveolar hemorrhage: A systematic review. Artif Organs. 2021;45:559\u201368. https:\/\/doi.org\/10.1111\/aor.13861.","journal-title":"Artif Organs"},{"key":"1227_CR64","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77:644\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211796.","journal-title":"Ann Rheum Dis"},{"key":"1227_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000007075","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, M\u00f8ller MH, Alshamsi F, Azevedo LCP, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026. https:\/\/doi.org\/10.1097\/CCM.0000000000007075.","journal-title":"Crit Care Med"},{"key":"1227_CR66","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/annrheumdis-2017-212861","volume":"77","author":"A Kronbichler","year":"2018","unstructured":"Kronbichler A, Kerschbaum J, Gopaluni S, Tieu J, Alberici F, Jones RB, et al. Trimethoprim-sulfamethoxazole prophylaxis prevents severe\/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2018;77:1440\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212861.","journal-title":"Ann Rheum Dis"},{"key":"1227_CR67","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DRW Jayne","year":"2000","unstructured":"Jayne DRW, Chapel H, Adu D, Misbah S, O\u2019Donoghue D, Scott D, et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM Int J Med. 2000;93:433\u20139. https:\/\/doi.org\/10.1093\/qjmed\/93.7.433.","journal-title":"QJM Int J Med"},{"key":"1227_CR68","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/art.39472","volume":"68","author":"E Crickx","year":"2016","unstructured":"Crickx E, Machelart I, Lazaro E, Kahn J-E, Cohen-Aubart F, Martin T, et al. Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients. Arthritis Rheumatol Hoboken N J. 2016;68:702\u201312. https:\/\/doi.org\/10.1002\/art.39472.","journal-title":"Arthritis Rheumatol Hoboken N J"},{"key":"1227_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejim.2023.06.021","volume":"117","author":"F Benavides-Villanueva","year":"2023","unstructured":"Benavides-Villanueva F, Loricera J, Calvo-R\u00edo V, Corrales-Selaya C, Casta\u00f1eda S, Blanco R. Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis. Eur J Intern Med. 2023;117:78\u201384. https:\/\/doi.org\/10.1016\/j.ejim.2023.06.021.","journal-title":"Eur J Intern Med"},{"key":"1227_CR70","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1093\/rheumatology\/keaf417","volume":"64","author":"A Granath","year":"2025","unstructured":"Granath A, Brolin S, Dahlberg K, Gunnarsson I, Welin E, Pettersson S. Exploration of health-related quality of life, anxiety and depression in antineutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Oxf Engl. 2025;64:6233\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/keaf417.","journal-title":"Rheumatol Oxf Engl"},{"key":"1227_CR71","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s10067-020-05398-5","volume":"40","author":"N Gill","year":"2021","unstructured":"Gill N, Tervaert JWC, Yacyshyn E. Vasculitis patient journey: a scoping review of patient experiences with vasculitis. Clin Rheumatol. 2021;40:1697\u2013708. https:\/\/doi.org\/10.1007\/s10067-020-05398-5.","journal-title":"Clin Rheumatol"},{"key":"1227_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12890-020-01181-z","volume":"20","author":"PG Park","year":"2020","unstructured":"Park PG, Yoo B-W, Song JJ, Park Y-B, Lee S-W. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis. BMC Pulm Med. 2020;20:147. https:\/\/doi.org\/10.1186\/s12890-020-01181-z.","journal-title":"BMC Pulm Med"},{"key":"1227_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.762004","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Guo J, Zhang P, Zhang L, Duan X, Shi X, et al. Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Front Med [Internet] Front. 2021. https:\/\/doi.org\/10.3389\/fmed.2021.762004. [cited 2026 Apr 4];8.","journal-title":"Front Med [Internet] Front"},{"key":"1227_CR74","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.ekir.2022.08.029","volume":"7","author":"F Aqeel","year":"2022","unstructured":"Aqeel F, Xu L, Tomar O, Duchen J, Li T, Geetha D. Practice Patterns of Induction Therapy in Severe Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Kidney Int Rep. 2022;7:2704\u20138. https:\/\/doi.org\/10.1016\/j.ekir.2022.08.029.","journal-title":"Kidney Int Rep"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01227-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:46:29Z","timestamp":1782463589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01227-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1227"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01227-x","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"20"}}